Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Yano

Showing results (801-810 of 839) with videos related to

Pageof 84
Sort By:
Clinical and Experimental Immunology|June 23, 2017
Calcineurin inhibitors exacerbate coronary arteritis via the MyD88 signalling pathway in a murine model of Kawasaki diseaseK Murata, Y Motomura, T Tanaka, et al.
Bone Marrow Transplantation|February 1, 1997
The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cellsY Katayama, T Yano, A Bessho, et al.
Transplantation Proceedings|April 29, 2014
Bile CXC motif chemokine 10 levels correlate with anti-donor cytotoxic T cell responses after liver transplantationH Morimoto, K Ide, Y Tanaka, et al.
British Journal of Cancer|February 18, 2010
Identification of DBC1 as a transcriptional repressor for BRCA1H Hiraike, O Wada-Hiraike, S Nakagawa, et al.
Transplantation Proceedings|April 29, 2014
Clinical efficacy of simultaneous splenectomy in liver transplant recipients with hepatitis C virusH Morimoto, K Ishiyama, M Ishifuro, et al.
British Journal of Cancer|March 17, 2011
Multifunctional transcription factor TFII-I is an activator of BRCA1 functionM Tanikawa, O Wada-Hiraike, S Nakagawa, et al.
British Journal of Cancer|November 16, 2013
Role of multifunctional transcription factor TFII-I and putative tumour suppressor DBC1 in cell cycle and DNA double strand damage repairM Tanikawa, O Wada-Hiraike, N Yoshizawa-Sugata, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
<i>ATP1A1</i> -linked diseases require a malfunctioning protein product from one alleleKerri Spontarelli, Victoria C Young, Ryan Sweazey, et al.
ESMO Gastrointestinal Oncology|May 28, 2026
A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trialD Okemoto, D Kotani, M Nakamura, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|September 2, 2023
ATP1A1-linked diseases require a malfunctioning protein product from one alleleKerri Spontarelli, Victoria C Young, Ryan Sweazey, et al.
Pageof 84

Showing results (801-810 of 839) with videos related to

Sort By:
Pageof 84
Clinical and Experimental Immunology|June 23, 2017
Calcineurin inhibitors exacerbate coronary arteritis via the MyD88 signalling pathway in a murine model of Kawasaki diseaseK Murata, Y Motomura, T Tanaka, et al.
Bone Marrow Transplantation|February 1, 1997
The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cellsY Katayama, T Yano, A Bessho, et al.
Transplantation Proceedings|April 29, 2014
Bile CXC motif chemokine 10 levels correlate with anti-donor cytotoxic T cell responses after liver transplantationH Morimoto, K Ide, Y Tanaka, et al.
British Journal of Cancer|February 18, 2010
Identification of DBC1 as a transcriptional repressor for BRCA1H Hiraike, O Wada-Hiraike, S Nakagawa, et al.
Transplantation Proceedings|April 29, 2014
Clinical efficacy of simultaneous splenectomy in liver transplant recipients with hepatitis C virusH Morimoto, K Ishiyama, M Ishifuro, et al.
British Journal of Cancer|March 17, 2011
Multifunctional transcription factor TFII-I is an activator of BRCA1 functionM Tanikawa, O Wada-Hiraike, S Nakagawa, et al.
British Journal of Cancer|November 16, 2013
Role of multifunctional transcription factor TFII-I and putative tumour suppressor DBC1 in cell cycle and DNA double strand damage repairM Tanikawa, O Wada-Hiraike, N Yoshizawa-Sugata, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
<i>ATP1A1</i> -linked diseases require a malfunctioning protein product from one alleleKerri Spontarelli, Victoria C Young, Ryan Sweazey, et al.
ESMO Gastrointestinal Oncology|May 28, 2026
A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trialD Okemoto, D Kotani, M Nakamura, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|September 2, 2023
ATP1A1-linked diseases require a malfunctioning protein product from one alleleKerri Spontarelli, Victoria C Young, Ryan Sweazey, et al.
Pageof 84